KPL-387

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387NCT07010159KNSAPhase 2, Phase 3Recruiting2027-12-31Estimated
Transition to KPL-387 Monotherapy Dosing & Administration StudyNCT07288216KNSAPhase 2Recruiting2027-12-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.